
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Carbonic Anhydrase Activators
Claudiu T. Supuran
Future Medicinal Chemistry (2018) Vol. 10, Iss. 5, pp. 561-573
Closed Access | Times Cited: 214
Claudiu T. Supuran
Future Medicinal Chemistry (2018) Vol. 10, Iss. 5, pp. 561-573
Closed Access | Times Cited: 214
Showing 1-25 of 214 citing articles:
Carbonic anhydrases: novel therapeutic applications for inhibitors and activators
Claudiu T. Supuran
Nature Reviews Drug Discovery (2008) Vol. 7, Iss. 2, pp. 168-181
Closed Access | Times Cited: 2968
Claudiu T. Supuran
Nature Reviews Drug Discovery (2008) Vol. 7, Iss. 2, pp. 168-181
Closed Access | Times Cited: 2968
Structure-based drug discovery of carbonic anhydrase inhibitors
Claudiu T. Supuran
Journal of Enzyme Inhibition and Medicinal Chemistry (2012) Vol. 27, Iss. 6, pp. 759-772
Open Access | Times Cited: 591
Claudiu T. Supuran
Journal of Enzyme Inhibition and Medicinal Chemistry (2012) Vol. 27, Iss. 6, pp. 759-772
Open Access | Times Cited: 591
Coral Calcification, Cells to Reefs
Denis Allemand, Éric Tambutté, Didier Zoccola, et al.
Springer eBooks (2010), pp. 119-150
Closed Access | Times Cited: 367
Denis Allemand, Éric Tambutté, Didier Zoccola, et al.
Springer eBooks (2010), pp. 119-150
Closed Access | Times Cited: 367
Carbonic Anhydrase Inhibitors and Activators for Novel Therapeutic Applications
Claudiu T. Supuran
Future Medicinal Chemistry (2011) Vol. 3, Iss. 9, pp. 1165-1180
Closed Access | Times Cited: 271
Claudiu T. Supuran
Future Medicinal Chemistry (2011) Vol. 3, Iss. 9, pp. 1165-1180
Closed Access | Times Cited: 271
Exploiting the hydrophobic and hydrophilic binding sites for designing carbonic anhydrase inhibitors
Giuseppina De Simone, Vincenzo Alterio, Claudiu T. Supuran
Expert Opinion on Drug Discovery (2013) Vol. 8, Iss. 7, pp. 793-810
Closed Access | Times Cited: 241
Giuseppina De Simone, Vincenzo Alterio, Claudiu T. Supuran
Expert Opinion on Drug Discovery (2013) Vol. 8, Iss. 7, pp. 793-810
Closed Access | Times Cited: 241
Carbonic Anhydrases and Metabolism
Claudiu T. Supuran
Metabolites (2018) Vol. 8, Iss. 2, pp. 25-25
Open Access | Times Cited: 183
Claudiu T. Supuran
Metabolites (2018) Vol. 8, Iss. 2, pp. 25-25
Open Access | Times Cited: 183
Carbonic anhydrase inhibitors and their potential in a range of therapeutic areas
Claudiu T. Supuran
Expert Opinion on Therapeutic Patents (2018) Vol. 28, Iss. 10, pp. 709-712
Open Access | Times Cited: 163
Claudiu T. Supuran
Expert Opinion on Therapeutic Patents (2018) Vol. 28, Iss. 10, pp. 709-712
Open Access | Times Cited: 163
Advances in the structural annotation of human carbonic anhydrases and impact on future drug discovery
Alessio Nocentini, Claudiu T. Supuran
Expert Opinion on Drug Discovery (2019) Vol. 14, Iss. 11, pp. 1175-1197
Closed Access | Times Cited: 147
Alessio Nocentini, Claudiu T. Supuran
Expert Opinion on Drug Discovery (2019) Vol. 14, Iss. 11, pp. 1175-1197
Closed Access | Times Cited: 147
Reconsidering anion inhibitors in the general context of drug design studies of modulators of activity of the classical enzyme carbonic anhydrase
Alessio Nocentini, Andrea Angeli, Fabrizio Carta, et al.
Journal of Enzyme Inhibition and Medicinal Chemistry (2021) Vol. 36, Iss. 1, pp. 561-580
Open Access | Times Cited: 104
Alessio Nocentini, Andrea Angeli, Fabrizio Carta, et al.
Journal of Enzyme Inhibition and Medicinal Chemistry (2021) Vol. 36, Iss. 1, pp. 561-580
Open Access | Times Cited: 104
A simple yet multifaceted 90 years old, evergreen enzyme: Carbonic anhydrase, its inhibition and activation
Claudiu T. Supuran
Bioorganic & Medicinal Chemistry Letters (2023) Vol. 93, pp. 129411-129411
Closed Access | Times Cited: 63
Claudiu T. Supuran
Bioorganic & Medicinal Chemistry Letters (2023) Vol. 93, pp. 129411-129411
Closed Access | Times Cited: 63
Carbonic anhydrase inhibitors: Interactions of phenols with the 12 catalytically active mammalian isoforms (CA I–XIV)
Alessio Innocenti, Daniela Vullo, Andrea Scozzafava, et al.
Bioorganic & Medicinal Chemistry Letters (2008) Vol. 18, Iss. 5, pp. 1583-1587
Open Access | Times Cited: 193
Alessio Innocenti, Daniela Vullo, Andrea Scozzafava, et al.
Bioorganic & Medicinal Chemistry Letters (2008) Vol. 18, Iss. 5, pp. 1583-1587
Open Access | Times Cited: 193
Carbonic Anhydrase Inhibitors Drug Design
Robert McKenna, Claudiu T. Supuran
Sub-cellular biochemistry/Subcellular biochemistry (2013), pp. 291-323
Closed Access | Times Cited: 128
Robert McKenna, Claudiu T. Supuran
Sub-cellular biochemistry/Subcellular biochemistry (2013), pp. 291-323
Closed Access | Times Cited: 128
Exploring the multiple binding modes of inhibitors to carbonic anhydrases for novel drug discovery
Claudiu T. Supuran
Expert Opinion on Drug Discovery (2020) Vol. 15, Iss. 6, pp. 671-686
Closed Access | Times Cited: 115
Claudiu T. Supuran
Expert Opinion on Drug Discovery (2020) Vol. 15, Iss. 6, pp. 671-686
Closed Access | Times Cited: 115
Carbonic anhydrase IX is a pH-stat that sets an acidic tumour extracellular pH in vivo
Shen‐Han Lee, Dominick J. O. McIntyre, Davina J. Honess, et al.
British Journal of Cancer (2018) Vol. 119, Iss. 5, pp. 622-630
Open Access | Times Cited: 105
Shen‐Han Lee, Dominick J. O. McIntyre, Davina J. Honess, et al.
British Journal of Cancer (2018) Vol. 119, Iss. 5, pp. 622-630
Open Access | Times Cited: 105
Applications of carbonic anhydrases inhibitors in renal and central nervous system diseases
Claudiu T. Supuran
Expert Opinion on Therapeutic Patents (2018) Vol. 28, Iss. 10, pp. 713-721
Closed Access | Times Cited: 101
Claudiu T. Supuran
Expert Opinion on Therapeutic Patents (2018) Vol. 28, Iss. 10, pp. 713-721
Closed Access | Times Cited: 101
3-Hydrazinoisatin-based benzenesulfonamides as novel carbonic anhydrase inhibitors endowed with anticancer activity: Synthesis, in vitro biological evaluation and in silico insights
Mahmoud F. Abo-Ashour, Wagdy M. Eldehna, Alessio Nocentini, et al.
European Journal of Medicinal Chemistry (2019) Vol. 184, pp. 111768-111768
Closed Access | Times Cited: 79
Mahmoud F. Abo-Ashour, Wagdy M. Eldehna, Alessio Nocentini, et al.
European Journal of Medicinal Chemistry (2019) Vol. 184, pp. 111768-111768
Closed Access | Times Cited: 79
Coumarin carbonic anhydrase inhibitors from natural sources
Claudiu T. Supuran
Journal of Enzyme Inhibition and Medicinal Chemistry (2020) Vol. 35, Iss. 1, pp. 1462-1470
Open Access | Times Cited: 75
Claudiu T. Supuran
Journal of Enzyme Inhibition and Medicinal Chemistry (2020) Vol. 35, Iss. 1, pp. 1462-1470
Open Access | Times Cited: 75
Hypertension and hyperhomocysteinemia as modifiable risk factors for Alzheimer's disease and dementia: New evidence, potential therapeutic strategies, and biomarkers
Ashley M Carey, Silvia Fossati
Alzheimer s & Dementia (2022) Vol. 19, Iss. 2, pp. 671-695
Open Access | Times Cited: 43
Ashley M Carey, Silvia Fossati
Alzheimer s & Dementia (2022) Vol. 19, Iss. 2, pp. 671-695
Open Access | Times Cited: 43
Amino Acid-Mediated Synthesis of the ZIF-8 Nanozyme That Reproduces Both the Zinc-Coordinated Active Center and Hydrophobic Pocket of Natural Carbonic Anhydrase
Shixuan Sun, Zijin Zhang, Yong Xiang, et al.
Langmuir (2022) Vol. 38, Iss. 4, pp. 1621-1630
Closed Access | Times Cited: 40
Shixuan Sun, Zijin Zhang, Yong Xiang, et al.
Langmuir (2022) Vol. 38, Iss. 4, pp. 1621-1630
Closed Access | Times Cited: 40
An overview of novel antimicrobial carbonic anhydrase inhibitors
Claudiu T. Supuran
Expert Opinion on Therapeutic Targets (2023) Vol. 27, Iss. 10, pp. 897-910
Closed Access | Times Cited: 31
Claudiu T. Supuran
Expert Opinion on Therapeutic Targets (2023) Vol. 27, Iss. 10, pp. 897-910
Closed Access | Times Cited: 31
Carbonic anhydrases reduce the acidity of the tumor microenvironment, promote immune infiltration, decelerate tumor growth, and improve survival in ErbB2/HER2-enriched breast cancer
Soojung Lee, Nicolai J. Toft, Trine V. Axelsen, et al.
Breast Cancer Research (2023) Vol. 25, Iss. 1
Open Access | Times Cited: 23
Soojung Lee, Nicolai J. Toft, Trine V. Axelsen, et al.
Breast Cancer Research (2023) Vol. 25, Iss. 1
Open Access | Times Cited: 23
Multi- and poly-pharmacology of carbonic anhydrase inhibitors
Claudiu T. Supuran
Pharmacological Reviews (2024) Vol. 77, Iss. 1, pp. 100004-100004
Closed Access | Times Cited: 10
Claudiu T. Supuran
Pharmacological Reviews (2024) Vol. 77, Iss. 1, pp. 100004-100004
Closed Access | Times Cited: 10
Sildenafil is a strong activator of mammalian carbonic anhydrase isoforms I–XIV
Taha Abdulkadir Çoban, Şükrü Beydemir, İlhami Gücin, et al.
Bioorganic & Medicinal Chemistry (2009) Vol. 17, Iss. 16, pp. 5791-5795
Closed Access | Times Cited: 119
Taha Abdulkadir Çoban, Şükrü Beydemir, İlhami Gücin, et al.
Bioorganic & Medicinal Chemistry (2009) Vol. 17, Iss. 16, pp. 5791-5795
Closed Access | Times Cited: 119
Carbonic anhydrase III: A neglected isozyme is stepping into the limelight
Anna-Kaisa Harju, Fatemeh Bootorabi, Marianne Kuuslahti, et al.
Journal of Enzyme Inhibition and Medicinal Chemistry (2012) Vol. 28, Iss. 2, pp. 231-239
Closed Access | Times Cited: 88
Anna-Kaisa Harju, Fatemeh Bootorabi, Marianne Kuuslahti, et al.
Journal of Enzyme Inhibition and Medicinal Chemistry (2012) Vol. 28, Iss. 2, pp. 231-239
Closed Access | Times Cited: 88